Skip to main content
. 2020 Sep 9;44(5):1895–1904. doi: 10.3892/or.2020.7760

Figure 1.

Figure 1.

The level of CK1α mRNA is highly expressed and correlated with poor prognosis in patients with AML. (A) Bone marrow specimens from 67 patients with AML (61 newly diagnosed, 6 achieved CR) and 11 healthy donors were collected. The level of CK1α mRNA was determined by RT-qPCR and GAPDH was used as an internal reference. (B) The level of CK1α mRNA was showed in each FAB subtypes of 61 newly diagnosed patients with AML. (C) Kaplan-Meier survival analysis was performed based on the survival data of 163 AML patients and its CSNK1A1 expression information in the TCGA-LAML database using the UALCAN website. The upper quartile of the expression information was used as a boundary value and differences in survival distributions were evaluated by the log-rank test. CK1α, casein kinase 1α; AML, acute myeloid leukemia; TCGA, Cancer Genome Atlas.